BIO-TECHNE Corp Goodwill, Acquired During Period
BIO-TECHNE Corp (TECH) reported Goodwill, Acquired During Period of $104.65 million for the 12-month period ending 2024-06-30, per its 10-K filed 2025-08-22.
Financial Statements › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2025-08-22
- BIO-TECHNE Corp goodwill, acquired during period for the quarter ending 2024-06-30 was $2.10M, a 921.36% increase year-over-year.
- BIO-TECHNE Corp goodwill, acquired during period for the quarter ending 2024-03-31 was $0.00.
- BIO-TECHNE Corp goodwill, acquired during period for the quarter ending 2023-12-31 was -$14.00K.
- BIO-TECHNE Corp goodwill, acquired during period for the quarter ending 2023-09-30 was $102.56M, a 100.90% increase year-over-year.
- BIO-TECHNE Corp goodwill, acquired during period for fiscal 2024 was $104.65M, a 104.17% increase from fiscal 2023.
- BIO-TECHNE Corp goodwill, acquired during period for fiscal 2023 was $51.26M.
- BIO-TECHNE Corp goodwill, acquired during period for fiscal 2021 was $102.82M.
- BIO-TECHNE Corp goodwill, acquired during period for fiscal 2019 was $136.30M, a 613.77% increase from fiscal 2018.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month | Goodwill, Acquired During Period 12 month as first filed |
|---|---|---|---|---|---|
| 2024-06-30 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-22 | $2.10M derived: sum of 2 quarters · filed 2025-08-22 | $2.09M derived: sum of 3 quarters · filed 2025-08-22 | $104.65M 10-K · filed 2025-08-22 | |
| 2024-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-06 | -$14.00K derived: sum of 2 quarters · filed 2024-05-06 | $102.55M 10-Q · filed 2024-05-06 | $102.75M derived: sum of 4 quarters · filed 2024-05-06 | |
| 2023-12-31 | -$14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-07 | $102.55M 10-Q · filed 2024-02-07 | $102.75M derived: sum of 3 quarters · filed 2024-02-07 | $102.75M derived: sum of 4 quarters · filed 2024-02-07 | |
| 2023-09-30 | $102.56M 10-Q · filed 2023-11-07 | $102.77M derived: sum of 2 quarters · filed 2023-11-07 | $102.77M derived: sum of 3 quarters · filed 2023-11-07 | $102.77M derived: sum of 4 quarters · filed 2023-11-07 | |
| 2023-06-30 | $206.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | $206.00K derived: sum of 2 quarters · filed 2023-08-23 | $206.00K derived: sum of 3 quarters · filed 2023-08-23 | $51.26M 10-K · filed 2023-08-23 | |
| 2023-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-08 | $0.00 derived: sum of 2 quarters · filed 2023-05-08 | $51.05M 10-Q · filed 2023-05-08 | ||
| 2022-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-07 | $51.05M 10-Q · filed 2023-02-07 | |||
| 2022-09-30 | $51.05M 10-Q · filed 2022-11-07 | ||||
| 2022-03-31 | $4.41M 10-Q · filed 2022-05-09 | ||||
| 2021-06-30 | $102.82M 10-K · filed 2022-08-24 | ||||
| 2021-03-31 | $7.85M 10-Q · filed 2021-05-07 | ||||
| 2020-12-31 | $8.81M 10-Q · filed 2021-02-08 | ||||
| 2020-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | $0.00 derived: sum of 2 quarters · filed 2020-05-11 | $0.00 10-Q · filed 2020-05-11 | $12.65M derived: sum of 4 quarters · filed 2020-08-26 | |
| 2019-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-06 | $0.00 10-Q · filed 2020-02-06 | $12.65M derived: sum of 3 quarters · filed 2020-08-26 | $23.72M derived: sum of 4 quarters · filed 2020-08-26 | |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-06 | $12.65M derived: sum of 2 quarters · filed 2020-08-26 | $23.72M derived: sum of 3 quarters · filed 2020-08-26 | $29.92M derived: sum of 4 quarters · filed 2020-08-26 | |
| 2019-06-30 | $12.65M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-26 | $23.72M derived: sum of 2 quarters · filed 2020-08-26 | $29.92M derived: sum of 3 quarters · filed 2020-08-26 | $136.30M 10-K · filed 2020-08-26 | |
| 2019-03-31 | $11.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-07 | $17.27M derived: sum of 2 quarters · filed 2019-05-07 | $123.65M 10-Q · filed 2019-05-07 | $114.94M derived: sum of 4 quarters · filed 2019-11-06 | |
| 2018-12-31 | $6.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-07 | $112.58M 10-Q · filed 2019-02-07 | $103.88M derived: sum of 3 quarters · filed 2019-11-06 | $125.69M derived: sum of 4 quarters · filed 2019-11-06 | |
| 2018-09-30 | $106.38M 10-Q · filed 2018-11-07 | $97.68M derived: sum of 2 quarters · filed 2019-11-06 | $119.49M derived: sum of 3 quarters · filed 2019-11-06 | $120.88M derived: sum of 4 quarters · filed 2019-11-06 | |
| 2018-06-30 | -$8.70M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-11-06 | $13.11M derived: sum of 2 quarters · filed 2019-11-06 | $14.50M derived: sum of 3 quarters · filed 2019-11-06 | $19.10M 10-K/A · filed 2019-11-06 | |
| 2018-03-31 | $21.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | $23.20M derived: sum of 2 quarters · filed 2018-05-09 | $27.80M 10-Q · filed 2018-05-09 | $33.73M derived: sum of 4 quarters · filed 2018-08-27 | |
| 2017-12-31 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | $5.99M 10-Q · filed 2018-02-08 | $11.92M derived: sum of 3 quarters · filed 2018-08-27 | $22.89M derived: sum of 4 quarters · filed 2018-08-27 | |
| 2017-09-30 | $4.59M 10-Q · filed 2017-11-09 | $10.52M derived: sum of 2 quarters · filed 2018-08-27 | $21.49M derived: sum of 3 quarters · filed 2018-08-27 | $11.38M derived: sum of 4 quarters · filed 2018-08-27 | |
| 2017-06-30 | $5.93M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-27 | $16.90M derived: sum of 2 quarters · filed 2018-08-27 | $6.79M derived: sum of 3 quarters · filed 2018-08-27 | $147.48M 10-K · filed 2018-08-27 | |
| 2017-03-31 | $10.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-10 | $863.00K derived: sum of 2 quarters · filed 2017-05-10 | $141.56M 10-Q · filed 2017-05-10 | $139.47M derived: sum of 4 quarters · filed 2017-09-07 | |
| 2016-12-31 | -$10.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | $130.59M 10-Q · filed 2017-02-09 | $128.50M derived: sum of 3 quarters · filed 2017-09-07 | $137.22M derived: sum of 4 quarters · filed 2017-09-07 | |
| 2016-09-30 | $140.69M 10-Q · filed 2016-11-09 | $138.61M derived: sum of 2 quarters · filed 2017-09-07 | $147.32M derived: sum of 3 quarters · filed 2017-09-07 | $147.24M derived: sum of 4 quarters · filed 2017-09-07 | |
| 2016-06-30 | -$2.09M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | $6.63M derived: sum of 2 quarters · filed 2017-09-07 | $6.55M derived: sum of 3 quarters · filed 2017-09-07 | $49.55M 10-K · filed 2017-09-07 | $49.65M 10-K · filed 2016-08-29 |
| 2016-03-31 | $8.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-10 | $8.63M derived: sum of 2 quarters · filed 2016-05-10 | $51.63M 10-Q · filed 2016-05-10 | $53.23M derived: sum of 4 quarters · filed 2016-08-29 | |
| 2015-12-31 | -$81.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-09 | $42.92M 10-Q · filed 2016-02-09 | $44.52M derived: sum of 3 quarters · filed 2016-08-29 | $37.48M derived: sum of 4 quarters · filed 2016-08-29 | |
| 2015-09-30 | $43.00M 10-Q · filed 2015-11-09 | $44.60M derived: sum of 2 quarters · filed 2016-08-29 | $37.56M derived: sum of 3 quarters · filed 2016-08-29 | $140.94M derived: sum of 4 quarters · filed 2016-08-29 | |
| 2015-06-30 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-29 | -$5.44M derived: sum of 2 quarters · filed 2016-08-29 | $97.94M derived: sum of 3 quarters · filed 2016-08-29 | $254.14M 10-K · filed 2016-08-29 | |
| 2015-03-31 | -$7.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-11 | $96.34M derived: sum of 2 quarters · filed 2015-05-11 | $252.54M 10-Q · filed 2015-05-11 | ||
| 2014-12-31 | $103.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-09 | $259.58M 10-Q · filed 2015-02-09 | |||
| 2014-09-30 | $156.20M 10-Q · filed 2014-11-10 | ||||
| 2014-06-30 | $61.87M 10-K · filed 2015-08-31 | ||||
| 2012-06-30 | $0.00 10-K · filed 2012-08-29 | ||||
| 2011-06-30 | $62.87M 10-K · filed 2012-08-29 | ||||
| 2010-06-30 | $0.00 10-K · filed 2011-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |